SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001818382-23-000039
Filing Date
2023-06-09
Accepted
2023-06-09 16:04:49
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 humaoresales-3.htm S-3 234379
2 EX-4.1 humaoresales-3ex41.htm EX-4.1 158086
3 EX-5.1 humaoresales-3xex51.htm EX-5.1 9013
4 EX-23.2 humaoresales-3ex232.htm EX-23.2 2914
5 EX-FILING FEES humaoresales-3xex107.htm EX-FILING FEES 18020
6 cbletterheada.jpg GRAPHIC 20748
7 covingtonheader2.jpg GRAPHIC 11514
8 humacytea.jpg GRAPHIC 15450
  Complete submission text file 0001818382-23-000039.txt   478756
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272550 | Film No.: 231005196
SIC: 2836 Biological Products, (No Diagnostic Substances)